About Gary Sender
Gary Sender is a director at Apnimed.
Gary Sender reports to the SEC as a director or officer of 7 public companies, including Schrodinger (SDGR), Harmony Biosciences (HRMY) and iBio (IBIO).
Gary Sender first appears on SEC filings in 2015.
Experience
This experience comes from Gary Sender's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gary Sender in the role, so the role may have started earlier or lasted longer.
HT
Hula Therapeutics Current
Board Member
2026 – Present
Apnimed, Inc. Current
Director
2024 – Present · Public company (APMD)
Develops oral medicines for people with sleep apnea and other sleep-related breathing diseases.
HI
Harmony Biosciences Holdings, Inc. Current
Director
2020 – Present · Public company (HRMY)
II
iBio, Inc. Current
Director
2020 – Present · Public company (IBIO)
SD
Schrödinger Current
Board Member
2019 – Present
SI
Schrodinger, Inc.
Director
2020 – 2026 · Public company (SDGR)
NP
Nabriva Therapeutics plc
Chief Financial Officer
Consultant (2016 – 2024)
2016 – 2024 · Public company (NBRV)
NP
Nabriva Therapeutics Legacy plc
Chief Financial Officer
2017 · Public company (NBRV)
SI
Synergy Pharmaceuticals, Inc.
EVP and CFO
Chief Financial Officer (2015 – 2016)
2015 – 2016 · Public company (SGYP)
SP
Shire Pharmaceuticals
Senior Vice President Finance
2009 – 2015
TI
Tengion Inc
Chief Financial Officer
2004 – 2009
AR
Aramark
VP, Investor Relations
2003 – 2004
ME
Merck
VP, Controller, US Human Health (1990 – 2002)
Executive Director, JV and Vaccine Financial Services (1987 – 1999)
1987 – 2002
RC
RCA American Communications
Financial Analyst
1983 – 1985
Key Colleagues at Startups
The people Gary Sender works with at each company, as listed on that company's latest Form D.
Apnimed, Inc. · Form D, Mar 27, 2026
LM
Lawrence Miller
Executive officer and director
Paul Fonteyne
Director
DM
Dennis Molnar
Executive officer
Barry Wohl
Chief Business Officer
JA
Joseph Avellone
Director
FB
Francois Beaubien
Director
Chris Dimitropoulos
Director
KL
Kevin Lind
Chief Executive Officer and director
IC
Isaac Cheng
Director
RB
Ramzi Benamar
Chief Financial Officer